GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

A · Jul 31, 2026

AGILENT TECHNOLOGIES, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001090872-26-000064General Corporate
Debt relative to revenue90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

194.09% · OPTIONAL · VALID

Capex intensity30thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.26% · OPTIONAL · VALID

Operating cash generation85thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

27.64% · OPTIONAL · VALID

Revenue growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

8.06% · CORE · VALID

Inventory pressure70thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

59.48% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

55.48% · CORE · VALID

Operating margin90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

23.64% · CORE · VALID

R&D intensity15thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6.55% · OPTIONAL · VALID

SBC intensity20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.65% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History40 statesSelf-history eligible
Oct 31, 20218/8 normalizedLevel 3Jan 31, 20229/9 normalizedLevel 3Apr 30, 20229/9 normalizedLevel 3Jul 31, 20229/9 normalizedLevel 3Oct 31, 20229/9 normalizedLevel 3Jan 31, 20239/9 normalizedLevel 3Apr 30, 20239/9 normalizedLevel 3Jul 31, 20239/9 normalizedLevel 3Oct 31, 20239/9 normalizedLevel 3Jan 31, 20249/9 normalizedLevel 3Apr 30, 20249/9 normalizedLevel 3Jul 31, 20249/9 normalizedLevel 3Oct 31, 20249/9 normalizedLevel 3Jan 31, 20259/9 normalizedLevel 3Apr 30, 20259/9 normalizedLevel 3Jul 31, 20259/9 normalizedLevel 3Oct 31, 20259/9 normalizedLevel 3Jan 31, 20269/9 normalizedLevel 3Apr 30, 20269/9 normalizedLevel 3Jul 31, 20269/9 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
166.27%
Current
194.09%
Delta
27.82%
Capex Intensity Increased
Previous
4.14%
Current
4.26%
Delta
0.12%
Cash Generation Increased
Previous
15.10%
Current
27.64%
Delta
12.54%
Growth Decreased
Previous
10.01%
Current
8.06%
Delta
-1.96%
Inventory Pressure Increased
Previous
59.35%
Current
59.48%
Delta
0.13%
Margin Increased
Previous
53.95%
Current
55.48%
Delta
1.53%
Profitability Increased
Previous
21.74%
Current
23.64%
Delta
1.90%
R And D Intensity Decreased
Previous
6.87%
Current
6.55%
Delta
-0.32%
Sbc Intensity Decreased
Previous
1.85%
Current
1.65%
Delta
-0.20%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Jul 31, 2021
Similarity
72%
Compared
9 dimensions
Coverage
100%
Growth 35.0 · Margin 57.9 · Profitability 4.7 · Sbc Intensity 32.6 · Capex Intensity 31.1 · Cash Generation 12.8 · R And D Intensity 9.7 · Inventory Pressure 12.1 · Balance Sheet Leverage 4.3
Apr 30, 2023
Similarity
70%
Compared
9 dimensions
Coverage
100%
Growth 15.0 · Margin 60.0 · Profitability 15.0 · Sbc Intensity 20.0 · Capex Intensity 20.0 · Cash Generation 0.0 · R And D Intensity 35.0 · Inventory Pressure 30.0 · Balance Sheet Leverage 30.0
Jul 31, 2022
Similarity
66%
Compared
9 dimensions
Coverage
100%
Growth 1.8 · Margin 20.0 · Profitability 10.0 · Sbc Intensity 40.0 · Capex Intensity 65.0 · Cash Generation 45.0 · R And D Intensity 10.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 37.1
Apr 30, 2026
Similarity
63%
Compared
9 dimensions
Coverage
100%
Growth 15.0 · Margin 40.0 · Profitability 40.0 · Sbc Intensity 45.0 · Capex Intensity 5.0 · Cash Generation 75.0 · R And D Intensity 20.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 25.0
Jan 31, 2025
Similarity
61%
Compared
9 dimensions
Coverage
100%
Growth 25.0 · Margin 70.0 · Profitability 30.0 · Sbc Intensity 60.0 · Capex Intensity 55.0 · Cash Generation 10.0 · R And D Intensity 10.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 10.0
Research Graph

Related governed research

Analogous To · A state analogue 3 →Analogous To · A state analogue 1 →Analogous To · A state analogue 5 →Analogous To · A state analogue 2 →Compared To · Laboratory Analytical Instruments peers →Analogous To · A state analogue 4 →Has State · AGILENT TECHNOLOGIES, INC. →Transitioned To · A Fundamental State →Transitioned To · A BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · A CAPEX_INTENSITY_INCREASED →Transitioned To · A CASH_GENERATION_INCREASED →Transitioned To · A GROWTH_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.